Description
6-Azathymidine, a nucleoside analog, is a potent inhibitor of DNA synthesis and has been clinically approved for its efficacy in treating chronic hepatitis B virus (HBV) infection. In addition to its antiviral properties, ongoing research has revealed its probable efficacy as a novel therapeutic agent for solid tumors including pancreatic and lung cancer. The medicinal properties of this unique compound have garnered significant attention and require further exploration in order to ascertain its full therapeutic potential